Literature DB >> 15832090

Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.

Baishali Bhattacharya1, Harrison Parry Dilworth, Christine Iacobuzio-Donahue, Francesca Ricci, Kristin Weber, Mary A Furlong, Cyril Fisher, Elizabeth Montgomery.   

Abstract

Deep fibromatoses (desmoid tumors) are clonal myofibroblastic proliferations that are prone to aggressive local recurrences but that do not metastasize. They must be distinguished from a host of fibroblastic and myofibroblastic lesions as well as from smooth muscle neoplasms. Virtually all deep fibromatoses have somatic beta-catenin or adenomatous polyposis coli (APC) gene mutations leading to intranuclear accumulation of beta-catenin. Since low-grade sarcomas in general lack beta-catenin and since reactive proliferations would not be expected to have it, we predicted that nuclear beta-catenin expression would be detected in deep fibromatoses but absent in other entities in the differential diagnosis. We evaluated the role of beta-catenin to help differentiate distinguish deep fibromatoses from congeners. Formalin-fixed, paraffin-embedded sections from 21 lesions from 20 patients with deep fibromatoses were stained with monoclonal beta-catenin antibody (Transduction Laboratories) and compared with low-grade fibromyxoid sarcoma (n=12), leiomyosarcoma (n=10), various other fibrosarcoma variants (n=13, including 3 myofibrosarcomas, 3 sclerosing epithelioid fibrosarcomas, 5 low-grade fibrosarcomas, 1 classic fibrosarcoma arising in dermatofibrosarcoma protuberans, 1 inflammatory myxohyaline tumor/myxoinflammatory fibroblastic sarcoma), myofibroma/myofibromatosis (n=12), nodular fasciitis (n=11), and scars (n=9). Nuclear and cytoplasmic staining was assessed. All 21 examples of deep fibromatosis displayed nuclear beta-catenin (focal nuclear staining in one case to 90% staining). All other lesions tested (n=67) lacked nuclear labeling for beta-catenin, showing only cytoplasmic accumulation. beta-Catenin immunohistochemistry separates deep fibromatosis from entities in the differential diagnosis, a finding that can be exploited for diagnosis. Most fibromatoses have diffuse nuclear staining although occasional examples only focally label.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832090     DOI: 10.1097/01.pas.0000157938.95785.da

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  51 in total

1.  Mesenteric fibromatosis of the transverse colon with the reconstruction of the superior mesenteric arteries: report of a case.

Authors:  Makoto Seki; Rintaro Koga; Akio Saiura; Ken Nakagawa; Kazuyoshi Kawabata; Hiroaki Kanda; Mutsuo Machinami; Masaru Nakagawa
Journal:  Surg Today       Date:  2012-05-18       Impact factor: 2.549

2.  Exploration of the APC/beta-catenin (WNT) pathway and a histologic classification system for pulmonary artery intimal sarcoma. A study of 18 cases.

Authors:  A Gaumann; B Bode-Lesniewska; D R Zimmermann; J C Fanburg-Smith; C J Kirkpatrick; F Hofstädter; M Woenckhaus; R Stoehr; E C Obermann; W Dietmaier; A Hartmann
Journal:  Virchows Arch       Date:  2008-09-20       Impact factor: 4.064

3.  [Intramuscular nodular fasciitis--a clinicopathological study with emphasis on myogenic giant cells].

Authors:  T Hansen; K Katenkamp; D Katenkamp
Journal:  Pathologe       Date:  2006-05       Impact factor: 1.011

4.  Aggressive fibromatosis of the mandible in a two-month old infant.

Authors:  Achamangalam Nandakumar Arya; Balasubramaniam Saravanan; Krishnamurthi Subalakshmi; Rajendiran Appadurai; Irulandy Ponniah
Journal:  J Maxillofac Oral Surg       Date:  2012-11-30

5.  Articular nodular fasciitis of the right shoulder joint: report of an unusual case with focus on immunohistochemical differential diagnosis.

Authors:  Shogo Tajima; Tomoyukisu Zuki; Kenji Koda
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 6.  New tumor entities in the 4th edition of the World Health Organization classification of head and neck tumors: Nasal cavity, paranasal sinuses and skull base.

Authors:  Lester D R Thompson; Alessandro Franchi
Journal:  Virchows Arch       Date:  2017-04-25       Impact factor: 4.064

7.  Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors.

Authors:  Nicholas A Mignemi; Doha M Itani; John H Fasig; Vicki L Keedy; Kenneth R Hande; Brent W Whited; Kelly C Homlar; Hernan Correa; Cheryl M Coffin; Jennifer O Black; Yajun Yi; Jennifer L Halpern; Ginger E Holt; Herbert S Schwartz; Jonathan G Schoenecker; Justin M M Cates
Journal:  Cancer Sci       Date:  2012-11-15       Impact factor: 6.716

8.  Abdominal wall fibromatosis associated with previous laparoscopic hernia repair.

Authors:  S B F Brown; E MacDuff; P J O'Dwyer
Journal:  Hernia       Date:  2013-04-09       Impact factor: 4.739

9.  Plexiform fibromyxoma with cotyledon-like serosal growth: A case report of a rare gastric tumor and review of the literature.

Authors:  Joshua Robert Kane; Natasha Lewis; Rebecca Lin; Celina Villa; Alexandra Larson; Jeffrey D Wayne; Anjana V Yeldandi; William B Laskin
Journal:  Oncol Lett       Date:  2016-02-04       Impact factor: 2.967

Review 10.  Sclerosing epithelioid fibrosarcoma: case presentation and a systematic review.

Authors:  Christian Ossendorf; Gabriela M Studer; Beata Bode; Bruno Fuchs
Journal:  Clin Orthop Relat Res       Date:  2008-03-14       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.